990KRW
27.44 BKRW
361.11 BKRW
17.33 M
About DONGWHA PHARM
Sector
CEO
Jun-Ha Yoo
Headquarters
Seoul
Website
Employees (FY)
826
Founded
1897
ISIN
KR7000020008
FIGI
BBG000BDH7Q6
Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digestion, skin scars, general cold, gum treatment, high blood pressure, infection, gastrointestinal tract control, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 000020 is 8400.00 KRW — it has decreased by 2.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGWHA PHARM stocks are traded under the ticker 000020.
DONGWHA PHARM is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track DONGWHA PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 000020 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGWHA PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 826.00 employees. See our rating of the largest employees — is DONGWHA PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGWHA PHARM EBITDA is 31.45 B KRW, and current EBITDA margin is 8.80%. See more stats in DONGWHA PHARM financial statements.